Premas Life Sciences Private Limited - Company Profile

It is a healthcare private limited company based in New Delhi, Delhi, India, established in 2011.

2011 New Delhi, Delhi, India Active

Last Updated: December 22, 2025

About Premas Life Sciences Private Limited

Premas Life Sciences Private Limited, a active private limited company, was established on 15 April 2011 in New Delhi, Delhi, India. Engaging in medical equipment retail & distribution within the professional, scientific and technical sector, it holds CIN: U51909DL2011PTC217592. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹30.00 Cr and a paid-up capital of ₹28.73 Cr.

It upholds a compliant status. Employing 88 professional, Its leadership includes Debjit Patra (Director), Praveen Kumar Gupta (Managing Director), Ashok Jain (Cfo). Past directors included Narahari Kousik, Debjit Patra, Praveen Kumar Gupta. It holds ₹132.00 Cr open charges and no settled loans. Its latest AGM occurred on 28 August 2024, with the balance sheet filed on 31 March 2024. It is based at Second Floor, E-49/5 Okhla Industrial Estate, Phase-Ii, New Delhi, Delhi, 110020.

Company Details

CIN/LLPIN
U51909DL2011PTC217592
Registration Number
217592
Incorporation Date
15 April 2011
Authorized Capital
₹30.00 Cr
Paid-Up Capital
₹28.73 Cr
ROC Code
Roc Delhi
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 30.00 Cr as on 22-12-2025
Paid Up Capital ₹ 28.73 Cr as on 22-12-2025
Company Age 14 Year, 9 Months
Last Filing with ROC 31 Mar 2024
Open Charges ₹ 132.00 Cr as on 22-12-2025
Revenue Growth **** -21.23% (FY 2023)
Profit Growth **** -45.23% (FY 2023)
Ebitda **** -45.72% (FY 2023)
Net Worth 24.28% (FY 2023)
Total Assets **** 6.62% (FY 2023)

Comprehensive Company Insights

Explore comprehensive insights into Premas Life Sciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Premas Life Sciences Private Limited?

Current Directors

Name	Designation	Appointment Date	Status
Debjit Patra	Director	20 Mar 2016	Current
Praveen Kumar Gupta	Managing Director	15 Apr 2011	Current
Ashok Jain	Cfo	09 Sep 2022	Current
Avijit Das	Director	15 Apr 2011	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Additional Director	14 Oct 2011	Past
Pramod Abcsdd	Additional Director	24 Sep 2016	Past
Pramod Abcsdd	Director	17 Jul 2018	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Premas Life Sciences.

Premas Life Sciences Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 21.23% decrease. The company also saw a substantial fall in profitability, with a 45.23% decrease in profit. The company's net worth Soared by an impressive increase of 24.28%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

-21.23%

*******

Revenue from Operations

*******

-21.75%

*******

Total Assets

*******

6.62%

*******

Profit or Loss

*******

-45.23%

*******

Net Worth

*******

24.28%

*******

EBITDA

*******

-45.72%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Premas Life Sciences?

In 2023, Premas Life Sciences had a promoter holding of 93.12% and a public holding of 6.87%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹1,320,000,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions

Hdfc Bank Limited : 80.00 Cr
Others : 27.00 Cr
Citi Bank N.A. : 25.00 Cr

Latest Charge Details

Date	Lender	Amount	Status
22 Dec 2021	Others	₹27.00 Cr	Open
29 Nov 2021	Hdfc Bank Limited	₹80.00 Cr	Open
14 Mar 2019	Citi Bank N.A.	₹25.00 Cr	Open

Explore comprehensive loan charge details -

How Many Employees Work at Premas Life Sciences?

Premas Life Sciences has a workforce of 88 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Premas Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Premas Life Sciences's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Premas Life Sciences

Recent Activity within the Organization

Charges

A charge with Hdfc Bank Limited of Rs. 80.00 Cr registered on 29 Nov 2021 with Charge ID 100504820 was modified on 26 Aug 2025. was recorded as a recent event.
26 Aug 2025
Annual General Meeting

The activity Premas Life Sciences Private Limited last Annual general meeting of members was held on 28 Aug 2024 as per latest MCA records. was completed.
28 Aug 2024
Charges

The activity A charge with Others of Rs. 27.00 Cr registered on 22 Dec 2021 with Charge ID 100535456 was modified on 01 Jul 2024. was completed.
01 Jul 2024
Balance Sheet

Premas Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was recorded as a recent event.
31 Mar 2024
Charges

Progress on A charge with Citi Bank N.A. of Rs. 25.00 Cr registered on 14 Mar 2019 with Charge ID 100271765 was modified on 27 Jul 2023. was documented.
27 Jul 2023
Director Appointment

Progress on Ritika Mundra was appointed as a Company Secretary was appointed as a Company Secretary on 16 Feb 2023 & has been associated with this company since 2 years 11 months . was documented.
16 Feb 2023

Explore recent activity and updates - View Recent Activity